Alzheimer's Disease: Drug Discovery

Alzheimer’s disease is the most common cause of age-related dementia. Alzheimer’s disease presents with irreversible cognitive decline, which commences as insidious short-term memory dysfunction and gradually spreads to other cognitive domains, rendering patients mute and non-ambulatory after 10-15...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Μορφή:	Online
Γλώσσα:	Αγγλικά
Έκδοση:	Exon Publications 2022
Θέματα:	Etiology of Alzheimer’s Disease; Epidemiology of Alzheimer’s Disease; Neuropathology of Alzheimer’s Disease; Pathogenesis of Alzheimer’s Disease; Immunotherapy for Alzheimer’s Disease; Amyloid β-Targeted Inhibitory Peptides for Alzheimer’s Disease; Tau Protein-Targeted Therapies in Alzheimer’s Disease; Targeting Metal Homeostasis for Alzheimer’s Disease; Insulin-Resistant in Alzheimer’s Disease; Blood–Brain Barrier in Alzheimer’s Disease; Epigenetic Modifications in Alzheimer’s Disease; Chimeric Conjugates for Alzheimer’s Disease; Multifunctional Ligand Approach for Alzheimer’s Disease; Natural Products for Alzheimer’s Disease MJND
Διαθέσιμο Online:	https://directory.doabooks.org/handle/20.500.12854/81835.3
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!